Libra Infusions Ltd. announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was BDT 51.750 million compared to BDT 69.862 million a year ago. Operating income was BDT 1.552 million compared to BDT 12.491 million a year ago. Net loss was BDT 12.248 million compared to net income of BDT 6.129 million a year ago. Basic loss per share was BDT 9.79 compared to basic earnings per share of BDT 4.9 a year ago. For the half year, sales was BDT 125.915 million compared to BDT 120.141 million a year ago. Operating income was BDT 8.133 million compared to BDT 7.738 million a year ago. Net loss was BDT 10.051 million compared to net income of BDT 51,557 a year ago. Basic loss per share was BDT 8.03 compared to basic earnings per share of BDT 0.04 a year ago.